Kinderarztpraxis Leyental
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
The pediatric clinic at Kinderarztpraxis Leyental focuses on protecting children from serious bacterial threats such as meningococcal disease. Current studies aim to evaluate the safety and immune protection offered by a new pentavalent meningococcal vaccine across different age groups.
- Assessment of vaccine safety in infants, toddlers, and children
- Measurement of antibody response against multiple meningococcal serogroups
- Comparison with existing meningococcal vaccines
- Long‑term monitoring of immunogenicity in the pediatric population
Through these investigations, Kinderarztpraxis Leyental contributes to national immunization strategies and helps ensure that young patients receive effective protection against bacterial infections.
Virus Diseases
In the viral disease portfolio, the practice conducts a vaccine trial targeting Respiratory Syncytial Virus (RSV) in infants and toddlers. The study seeks to demonstrate how the candidate RSV vaccine can prevent lower respiratory tract illness during the RSV season.
- Evaluation of vaccine efficacy in preventing RSV‑related lower respiratory illness
- Monitoring of safety outcomes in young children
- Analysis of immune response after the two‑dose schedule
- Impact assessment on RSV season disease burden
Results from this work aim to fill a critical gap in pediatric viral infection prevention and may shape future vaccination recommendations across Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 59 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 59 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Sanofi Pasteur Inc.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kinderarztpraxis Leyental
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine in Pediatric Populations Compared to Licensed Meningococcal Vaccines | Sanofi Pasteur Inc. | Phase II | Not Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 59 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 534 | 1 | Unknown | 2024-08-09 | 2024-08-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.